Faculty Profiles - OMAE Kenji

Papers - OMAE Kenji

Division display81 - 100 of about 167／ All the affair displays >>

Salt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study.

Iida H, Kurita N, Takahashi S, Sasaki S, Nishiwaki H, Omae K, Yajima N, Fukuma S, Hasegawa T, Fukuhara S, Sukagawa Study Group.

Journal of clinical hypertension (Greenwich, Conn.) 21 ( 7 ) 942 - 949 2019.7（ ISSN:1524-6175 ）

【CKD患者におけるがん化学療法-透析患者を中心に】がん薬物療法の特性　分子標的薬　mTOR阻害薬

大前憲史

臨床透析 35 ( 7 ) 790 - 797 2019.6（ ISSN:0910-5808 ）

Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional study.

Tanaka M, Nishiwaki H, Kado H, Doi Y, Ihoriya C, Omae K, Tamagaki K

BMC nephrology 20 ( 1 ) 121 2019.4

The effect of transportation modality to dialysis facilities on health-related quality of life among hemodialysis patients: results from the Japanese dialysis outcomes and practice pattern study

Yazawa M, Omae K, Shibagaki Y, Inaba M, Tsuruya K, Kurita N

Clinical Kidney Journal (in press) 2019

Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy.

Ishiyama R, Kondo T, Takagi T, Iizuka J, Kobayashi H, Omae K, Fukuda H, Ishihara H, Tanabe K

Journal of endourology 2018.9（ ISSN:0892-7790 ）

Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Iwamoto K, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K

Japanese journal of clinical oncology 48 ( 7 ) 667 - 672 2018.7（ ISSN:0368-2811 ）

転移性腎細胞癌の治療早期におけるスニチニブの相対用量強度減少は治療効果に影響する(Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma)

Ishihara Hiroki, Takagi Toshio, Kondo Tsunenori, Iwamoto Kana, Tachibana Hidekazu, Yoshida Kazuhiko, Omae Kenji, Iizuka Junpei, Kobayashi Hirohito, Tanabe Kazunari

Japanese Journal of Clinical Oncology 48 ( 7 ) 667 - 672 2018.7（ ISSN:0368-2811 ）

一次療法のVEGF受容体チロシンキナーゼ阻害剤療法および二次療法に抵抗性の転移性腎細胞癌における三次療法の分子標的療法の有効性および安全性(Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy)

Ishihara Hiroki, Takagi Toshio, Kondo Tsunenori, Tachibana Hidekazu, Yoshida Kazuhiko, Omae Kenji, Iizuka Junpei, Kobayashi Hirohito, Tanabe Kazunari

International Journal of Clinical Oncology 23 ( 3 ) 559 - 567 2018.6（ ISSN:1341-9625 ）

Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study.

Niihata K, Takahashi S, Kurita N, Yajima N, Omae K, Fukuma S, Okano T, Nomoto Y, Omori K, Fukuhara S, Sukagawa Study Group.

Journal of the American Medical Directors Association 19 ( 3 ) 235 - 239.e1 2018.3（ ISSN:1525-8610 ）

Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy.

Ishihara H, Takagi T, Kondo T, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K

International journal of clinical oncology 1 - 9 2018.1（ ISSN:1341-9625 ）

Dialysis physicians' referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study

Shingo Fukuma, Miho Kimachi, Kenji Omae, Yuki Kataoka, Yuki Kataoka, Hajime Yamazaki, Manabu Muto, Tadao Akizawa, Motoko Yanagita, Shunichi Fukuhara

PLoS ONE 13 ( 8 ) e0202322 2018

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.

Ishihara H, Kondo T, Fukuda H, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K

Japanese journal of clinical oncology 47 ( 12 ) 1175 - 1181 2017.12（ ISSN:0368-2811 ）

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma(和訳中)

Ishihara Hiroki, Kondo Tsunenori, Fukuda Hironori, Yoshida Kazuhiko, Omae Kenji, Takagi Toshio, Iizuka Junpei, Kobayashi Hirohito, Tanabe Kazunari

Japanese Journal of Clinical Oncology 47 ( 12 ) 1175 - 1181 2017.12（ ISSN:0368-2811 ）

Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K

Clinical genitourinary cancer 15 ( 5 ) 598 - 604 2017.10（ ISSN:1558-7673 ）

A novel approach of understanding prediction models: TRIPOD framework(和訳中)

Kataoka Yuki, Yamamoto Shungo, Omae Kenji, Kokubo Masayo, Goto Yoshihito, Takada Toshihiko, Naganuma Toru, Nishiwaki Hiroki, Yajima Nobuyuki

Journal of General and Family Medicine 18 ( 5 ) 319 - 320 2017.10（ ISSN:2189-6577 ）

A novel approach of understanding prediction models: TRIPOD framework.

Kataoka Y, Yamamoto S, Omae K, Kokubo M, Goto Y, Takada T, Naganuma T, Nishiwaki H, Yajima N

Journal of general and family medicine 18 ( 5 ) 319 - 320 2017.10（ ISSN:2189-6577 ）

Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis.

Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S, Furukawa TA

Oncotarget 8 ( 40 ) 68890 - 68898 2017.9

Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.

Omae K, Fukuma S, Ikenoue T, Kondo T, Takagi T, Ishihara H, Tanabe K, Fukuhara S

Urologic oncology 35 ( 9 ) 540.e7 - 540.e12 2017.9（ ISSN:1078-1439 ）

Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K

Urologic oncology 35 ( 9 ) 542.e1 - 542.e9 2017.9（ ISSN:1078-1439 ）

Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K

Urologic oncology 35 ( 9 ) 539.e9 - 539.e16 2017.9（ ISSN:1078-1439 ）

　 PREV - NEXT 　

<OMAE Kenji>

Papers - OMAE Kenji